Farmas USA

Respuestas: 88624

  1. #5705
    raclit
    en respuesta a framus_morrigan #5695

    Re: Farmas USA

    Ver mensaje de framus_morrigan

    vaya cierre!! ya curro mejor esta noche, que lo acabo de mirar!!

  2. #5706
    Eljuca
    en respuesta a Charabasca #5698

    Re: Farmas USA

    Ver mensaje de Charabasca

    Guardalo para el 27, S2

  3. #5707
    oliaras
    en respuesta a Romaov #1

    Re: Farmas USA

    Ver mensaje de Romaov

    Alguien me puede informar un poco de AMRN? Cuando tiene la fecha clave, de que medicamentos estamos hablando, los datos que tenemos...

    Os leo cada hora!

  4. #5708
    Prometeo13
    en respuesta a framus_morrigan #5701

    Re: Farmas USA

    Ver mensaje de framus_morrigan

    Ahora nuestro pullback ......@[email protected]

    Guardar

  5. #5709
    Eljuca
    en respuesta a framus_morrigan #5694

    Re: Farmas USA

    Ver mensaje de framus_morrigan

    esta me parece que es tuya,mira como se ha comportado hoy,tendremos que vigilarla

    IntelliPharmaCeutics Intl Inc (USA)(NASDAQ:IPCI

    3.05 +0.25 (8.93%)
    After Hours: 3.10 +0.05 (1.64%)

    Guardar

  6. #5710
    patiko7
    en respuesta a raclit #5704

    Re: Farmas USA

    Ver mensaje de raclit

    Click here to find out more!
    Arena Pharmaceuticals (ARNA) is Getting Closer and Closer to the Green Light

    FREE Breaking News Alerts from StreetInsider.com!
    E-mail Address
    Click here to find out more!
    Top News Most Read Highlighted

    Markets Get Whipsawed as Bernanke Speaks
    Fed Extends 'Operation Twist' Through End of 2012
    Forget QE3, the Fed Might Have Something Better
    Micron (MU) Slips Into the Red for Q3; Volumes Rose, as Did Costs
    Microsoft's (MSFT) 'Surface' Dead on Arrival

    Click here to find out more!
    June 20, 2012 4:36 PM EDT
    ARNA Hot Sheet
    Overall Analyst Rating:
    NEUTRAL (Up Up)

    EPS Growth %: +30.4%
    Another day... another hour... another minute... has gone by without Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announcing a PDUFA date delay for weight loss drug Lorcaserin.

    If Arena can avoid a delay this would be big news, since many analysts on the Street still expect Arena Pharmaceuticals will get a 3-6 month PDUFA date delay, although they ultimately expect the drug to be approved. Just look what JPMorgan's analyst said the other day:

    "PDUFA date for obesity drug lorcaserin on June 27th. Given the positive 18-4 AdCom vote in May, we expect lorcaserin to ultimately be approved. The question is when. While it is feasible that this could happen by June 27, we are anticipating some sort of delay. A number of panelists at the May AdCom mentioned their desire for a risk evaluation and mitigation strategy (REMS) and a post-approval CV outcomes trial (CVOT). Given that we are not sure how far along the FDA and ARNA are in finalizing either a REMS or a CVOT, we would not be surprised to see either a standard 3-month delay for a major amendment to the NDA (if ARNA submits a proposed REMS pre-PDUFA) or a complete response letter (CRL; if a REMS is not submitted) that could push the next regulatory decision into 1H13. While a positive AdCom vote is not a guarantee for a green light from the FDA (see OREX's Contrave), we assume a 70% probability of eventual approval, which is agnostic to a potential REMS-related delay."

    These comments from JPMorgan echoed other analysts.

    But as we noted yesterday, rival Vivus, Inc. (NASDAQ: VVUS) announced its PDUFA date delay just 8 days before the originally scheduled PDUFA. Now with just 7 days until the Arena's PDUFA date, while not impossible, it would be unprecedented to announce a delay at this point.

    Tick-tock, tick-tock. Every second that goes by means Arena is that much closer to gaining FDA approval and first-mover advantage.

    Illustrating the market's increased confidence, shares of Arena Pharmaceuticals closed up 8 percent today to a new 52-week high of $10.50.

    Guardar

  7. #5711
    raclit
    en respuesta a patiko7 #5710

    Re: Farmas USA

    Ver mensaje de patiko7

    me gusta!!

    y los analistas aun esperan retraso para sus intereses...jaja

    es que el cierre en máximos de la acción, ha sido genial!

  8. #5712
    Prometeo13
    en respuesta a jleon #5703

    Re: Farmas USA

    Ver mensaje de jleon

    Yo lo estuve estudiando y coincido, ni con un palo.
    Me sorprendió un poco la indicación.mas que nada por la divergencia que era bastante obvia.

    AMRN Espero que el banderín alcista claro claro de hace 2 dias pueda con tu " velita", tampoco es
    Ningún doji concluyente, no?. ;)))))))))

Sigue formándote con Rankia
Descarga las guías

¿Aún no eres usuario de Rankia?

Somos más de 140.000 usuarios
Regístrate y podrás:
  • Guardarte contenidos y usuarios
  • Participar en promociones especiales
  • Publicar mensajes en Foros y Opiniones
  • Participar en el Juego de Bolsa
  • Crear tu propia Cartera

Conoce la otra comunidad del grupo Emergia.

Verema: Vinos, Restaurantes, Enoturismo y Club de Vinos

Este sitio web usa cookies propias o de terceros para analizar la navegación del usuario. En caso de seguir navegando se entiende que acepta la política de cookies.
Aceptar